CA 125 and VAS Pain Score Changes to Diagnose Endometriosis

• Status: Completed
• Trial end date: 2014-01-01
• Target enrollment: 0
• Participant gender: Female

Summary

To assess the diagnostic accuracy for the noninvasive detection of pelvic endometriosis of the combination of two simple parameters: modifications of serum CA 125 and VAS pain score following one dose of GnRH-analog (GnRH-a).

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University Magna Graecia

Criteria

Inclusion Criteria:

• chronic pelvic pain

Exclusion Criteria:

• age less than 18 and greater than 38

• oligo-amenorrhea

• use of hormone medications (including oral contraceptives pill, progestogens, and so on)

• conditions affecting serum CA125 levels (such as, pregnancy, ovarian endometrioma seen at ultrasonography, pelvic inflammatory diseases, neoplasm, tuberculosis, hepatitis, peritonitis, recent abdominal surgery and pelvic organic disease)